Prime Medicine, Inc.
PRME
$1.24
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -42.28M | -52.52M | -55.33M | -45.76M | -65.64M |
| Total Depreciation and Amortization | 1.72M | 1.56M | 1.54M | 1.32M | 1.25M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.94M | 7.97M | 13.05M | 6.85M | 6.08M |
| Change in Net Operating Assets | 48.86M | 17.08M | -4.75M | -30.11M | 14.45M |
| Cash from Operations | 16.25M | -25.91M | -45.49M | -67.71M | -43.86M |
| Capital Expenditure | -1.79M | -1.28M | -1.90M | -2.32M | -1.84M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.04M | 51.62M | 8.80M | -34.71M | 43.13M |
| Cash from Investing | 48.25M | 50.34M | 6.89M | -37.03M | 41.29M |
| Total Debt Issued | -- | -- | -6.00M | 6.00M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.00K | 38.51M | -- | 151.33M | 194.00K |
| Repurchase of Common Stock | -- | -- | -18.77M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 24.80M | -- | -- |
| Cash from Financing | 1.00K | 38.51M | 35.00K | 157.33M | 194.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 64.50M | 62.94M | -38.56M | 52.59M | -2.39M |